PH12018550151A1 - Nutritional compositions and their use - Google Patents

Nutritional compositions and their use

Info

Publication number
PH12018550151A1
PH12018550151A1 PH12018550151A PH12018550151A PH12018550151A1 PH 12018550151 A1 PH12018550151 A1 PH 12018550151A1 PH 12018550151 A PH12018550151 A PH 12018550151A PH 12018550151 A PH12018550151 A PH 12018550151A PH 12018550151 A1 PH12018550151 A1 PH 12018550151A1
Authority
PH
Philippines
Prior art keywords
nutritional compositions
support
composition
infants
mammals
Prior art date
Application number
PH12018550151A
Inventor
Frederic Destaillats
Jonas Hauser
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from PCT/EP2016/080792 external-priority patent/WO2017167418A1/en
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of PH12018550151A1 publication Critical patent/PH12018550151A1/en

Links

Landscapes

  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Medicines Containing Plant Substances (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)

Abstract

The present invention concerns a nutritional composition to support, to promote, support a health status characterized by optimal brain and cognitive functions' development and/or prevention of neurocognitive deficits. This composition is for use in mammals, preferably in humans, for example in infants.
PH12018550151A 2016-03-30 2018-09-05 Nutritional compositions and their use PH12018550151A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
US201662315187P 2016-03-30 2016-03-30
US201662315280P 2016-03-30 2016-03-30
US201662328047P 2016-04-27 2016-04-27
EP16169351 2016-05-12
PCT/EP2016/080792 WO2017167418A1 (en) 2016-03-30 2016-12-13 Nutritional compositions and their use

Publications (1)

Publication Number Publication Date
PH12018550151A1 true PH12018550151A1 (en) 2019-03-25

Family

ID=65529106

Family Applications (1)

Application Number Title Priority Date Filing Date
PH12018550151A PH12018550151A1 (en) 2016-03-30 2018-09-05 Nutritional compositions and their use

Country Status (4)

Country Link
CL (1) CL2018002483A1 (en)
MX (1) MX2018011335A (en)
PH (1) PH12018550151A1 (en)
RU (1) RU2018138024A (en)

Also Published As

Publication number Publication date
RU2018138024A (en) 2020-04-30
CL2018002483A1 (en) 2019-01-04
MX2018011335A (en) 2019-01-31

Similar Documents

Publication Publication Date Title
PH12020550839A1 (en) Spray-dried sialyllactose
MX2018012655A (en) Compounds and methods for treating neurological and cardiovascular conditions.
PH12015502788A1 (en) Antibody formulations and methods
MX2017003966A (en) Cleaning and/or treatment compositions comprising malodor reduction compositions.
PH12016501307B1 (en) Compounds
TW201613880A (en) Crystalline solid forms of 6-carboxy-2-(3,5-dichlorophenyl)-benzoxazole
WO2016100157A3 (en) 6,5-bicyclic octahydropyrrolopyridine orexin receptor antagonists
WO2016100162A3 (en) 5,5-bicyclic oxazole orexin receptor antagonists
NZ730334A (en) Substituted 2-azabicycles and their use as orexin receptor modulators
MY183291A (en) Lactoferrin and brain health and development in infants
MX2019002924A (en) Purified human milk oligosaccharides compositions.
EP4218736A3 (en) Compositions comprising 15-hepe
TN2016000435A1 (en) Novel macrocyclic compounds.
PH12019502469A1 (en) Novel fragrance compositions and products with mood enhancing effects
PH12015502543B1 (en) Anti-regurgitation composition maintaining gut motility
MX2021003515A (en) Polymorphic compounds and uses thereof.
PH12019500535A1 (en) 7-substituted 1-aryl-naphthyridine-3-carboxylic acid amides and use thereof
ZA202001295B (en) Thiazolopyridine derivatives as adenosine receptor antagonists
MX2018008643A (en) 3-((hetero-)aryl)-8-amino-2-oxo-1,3-diaza-spiro-[4.5]-decane derivatives.
MX2020006140A (en) Cyclobenzaprine treatment for agitation, psychosis and cognitive decline in dementia and neurodegenerative conditions.
MX2017013278A (en) Osmanthus odorant.
PH12018550151A1 (en) Nutritional compositions and their use
BR112018067926A2 (en) nutritional compositions and their uses
MY182818A (en) Compositions for the treatment of fibrosis and fibrosis-related conditions
MX2021004804A (en) Novel organoleptic compounds.